Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Tianli Education (1773 HK) Grows Dramatically Without Typical Shortages, Upside 22%~43%

Key Risk to Private Schools: Property Developers Standing Behind

Virscend (1565HK) – Revenues Accelerated & Margin Improved in 2H17

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Tianli Education / Equity Capital Markets

<p>Tianli Education, a Western China-based K-12 education provider, is raising up to USD 195 million to list in Hong Kong. In this insight, we will cover the following topics:</p>
<ul>
<li>The company's operation and business segment,</li>
<li>Growth drivers and expansion plan, </li>
<li>Comparison of key metrics between the company and Virscend Education (1565 HK),</li>
<li>Thoughts on valuation</li>
</ul>

Tianli Education, a Western China-based K-12 education provider, is raising up to USD 195 million to list in Hong Kong. In this insight, we will cover the following topics:

The company's operation and business segment,
Growth drivers and expansion plan, 
Comparison of key metrics between the company and Virscend Education (1565 HK),
Thoughts on valuation


Tianli Education IPO: 고품질 순수 K-12 기업, 높은 성장세에도 불구하고 고가 수준에서 적정 가치 평가